|
Clearpoint Neuro Inc (NASDAQ: CLPT) |
|
Clearpoint Neuro Inc
CLPT's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Clearpoint Neuro Inc growth rates, revenue grew
by 40.96 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1466
Medical Equipment & Supplies industry recorded
growth of revenues by 1.72 %
Clearpoint Neuro Inc net loss increased from $-5 millions, to $-5 millions in III. Quarter 2024,
• More on CLPT's Growth
|
|
Clearpoint Neuro Inc realized a net loss in trailing twelve months.
Clearpoint Neuro Inc realized cash reduction of $ -0.1 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 16.67.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.49.
• More on CLPT's Valuation
|
|
|
|
|
Clearpoint Neuro Inc realized net loss in trailing twelve months.
Clearpoint Neuro Inc realized cash outflow of $ -0.1per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 16.67.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.49.
Clearpoint Neuro Inc Price to Book Ratio is at 17.49 higher than Industry Avg. of -174.49, and higher than S&P 500 Avg. of 0.02
• More on CLPT's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com